Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies.

Abstract excerpt

Asthma is a prevalent pulmonary disease that affects more than 300 million people worldwide and imposes a substantial economic burden. While medication can effectively control symptoms in some patients, severe asthma attacks, driven by airway inflammation induced by environmental and infectious exposures, continue to be a major cause of asthma-related mortality. Heterogeneous phenotypes of asthma include type 2...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anti-Asthmatic Agents
• Share to Asthma
• Share to Inflammasomes